Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT)

AIMS/INTRODUCTION: Tofogliflozin is a potent and highly selective sodium–glucose cotransporter 2 inhibitor, and is currently used to treat patients with type 2 diabetes mellitus. We designed a 3‐year study of tofogliflozin in patients with type 2 diabetes mellitus to evaluate the safety and effectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Investig
Main Authors: Utsunomiya, Kazunori, Kakiuchi, Seigo, Senda, Masayuki, Fujii, Shoko, Kurihara, Yuji, Gunji, Ryoji, Koshida, Ryusuke, Kameda, Hiroyuki, Tamura, Masahiro, Kaku, Kohei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378444/
https://ncbi.nlm.nih.gov/pubmed/32034997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados